Clinical trial
Procalcitonin-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations: a Prospective Randomised Controlled Trial
NCT05854901 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Procalcitonin-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations: a Prospective Randomised Controlled Trial
- Lead sponsor
- Erasmus Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 10, 2021
- Completion date
- August 6, 2026
- Enrollment
- 693 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
acute copd exacerbation, copd, copd exacerbation